Full name
INSTYTUT IMMUNOMEDICA SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ SPÓŁKA JAWNA
uses securityreCAPTCHA
86.10.Z - Hospital activities
47.29.Z - Other retail sale of food in specialised stores
47.78.Z - Other retail sale of new goods in specialised stores
47.91.Z - Retail sale via mail order houses or via Internet
47.99.Z - Other retail sale not in stores, stalls or markets
86.21.Z - General medical practice activities
86.22.Z - Specialist medical practice activities
86.90.C - Nurses and midwives activities
86.90.D - Paramedical activities
86.90.E - Other human health activities notelsewhere classified
2021 | 2022 | 2023 | ||
---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Profit (loss) on sale | 1,8 | 2,2 | 3 | 32,2 |
Gross profit (loss) | 1,9 | 2,2 | 3 | 33,3 |
EBITDA | 1,9 | 2,2 | 3 | 32,7 |
Short time liabilities | 0,3 | 0,4 | 0,3 | -26,6 |
Other operating costs | 0 | 0 | 0 | -87 |
Equity capital | 0,4 | 0,6 | 0,3 | -45,7 |
Operating profit (EBIT) | 1,9 | 2,2 | 3 | 32,9 |
Assets | 0,7 | 0,9 | 0,6 | -38,3 |
Net profit (loss) | 1,8 | 2,2 | 3 | 33,3 |
Cash | 0,2 | 0,4 | 0,2 | -47,1 |
Net income from sale | 6,2 | 6,5 | 8,5 | 31,4 |
Liabilities and provisions for liabilities | 0,3 | 0,4 | 0,3 | -26,6 |
Working assets | 0,7 | 0,9 | 0,6 | -38,3 |
Other income costs | 0,1 | 0 | 0 | -84,5 |
Depreciation | 0 | 0 | 0 | -100 |
% | % | % | p.p. | |
Profitability of capital | 523,1 | 395,4 | 971,5 | 576,1 |
Equity capital to total assets | 54 | 60,8 | 53,5 | -7,3 |
Gross profit margin | 30,4 | 34,3 | 34,8 | 0,5 |
EBITDA Margin | 30,8 | 34,4 | 34,7 | 0,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 18 | 20 | 11 | -9 |
Current financial liquidity indicator | 2.1816062927246094 | 2.5537731647491455 | 2.14890193939209 | -0,5 |
Net dept to EBITDA | -0.07695961743593216 | -0.15333376824855804 | -0.07064048200845718 | 0,1 |
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane